Key Laboratory of Hearing Medicine of NHFPC, ENT Institute and Otorhinolaryngology Department, Shanghai Engineering Research Centre of Cochlear Implant, Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200031, China.
Institutes of Biomedical Sciences and The Institutes of Brain Science and the Collaborative Innovation Center for Brain Science, Fudan University, Shanghai 200032, China.
Neural Plast. 2018 Jun 13;2018:7691473. doi: 10.1155/2018/7691473. eCollection 2018.
Sudden sensorineural hearing loss (SSHL) is a clinically common acute symptom in otolaryngology. Although the incidence of SSHL has increased around the world in recent years, the etiology of the disease is still unclear. It has been reported that infections, ototoxic drugs, membrane labyrinth rupture, carcinomas, circulatory system diseases, autoimmune diseases, brain lesions, mental diseases, congenital or inherited diseases, and so on, are all risk factors for SSHL. Here, we discuss the autoimmune mechanisms behind SSHL, which might be induced by type II-IV allergic reactions. We also introduce the main immunosuppressive medications that have been used to treat SSHL, which will help us to identify potential targets for immune therapy.
突发性聋(sudden sensorineural hearing loss,SSHL)是耳鼻喉科临床常见的急性症状。尽管近年来全球突发性聋的发病率有所增加,但该病的病因仍不清楚。据报道,感染、耳毒性药物、膜迷路破裂、癌肿、循环系统疾病、自身免疫性疾病、脑部病变、精神疾病、先天性或遗传性疾病等都是突发性聋的危险因素。在这里,我们讨论了突发性聋背后的自身免疫机制,这些机制可能是由 II-IV 型过敏反应引起的。我们还介绍了用于治疗突发性聋的主要免疫抑制药物,这将有助于我们确定免疫治疗的潜在靶点。